Riskpilot← Back to searchSign inGet full accessAbbott Rapid Diagnostics A/S
A/SActiveCVR 24204650Arne Jacobsens Allé 13, 2.Wholesale of pharmaceutical and medical goods · NACE 4646Est. 19992 employeeswww.alere.dk
Revenue 2024
DKK 2,2M
-64% vs 2023
EBITDA margin
25.7%
-51% vs 2023
Equity ratio
90.9%
Financial strength
Net profit 2024
DKK 854K
-30% vs 2023
| Revenue | DKK 2,2M | -64% |
| EBITDA | DKK 573K | -51% |
| Net profit | DKK 854K | -30% |
| Total assets | DKK 34,8M | +1% |
| Equity | DKK 31,7M | +3% |
| Employees | 2 | — |
Legal name
Abbott Rapid Diagnostics A/S
CVR number
24204650
Legal form
Aktieselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
1. oktober 1999
Share capital
DKK 600.000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af 2 bestyrelsesmedlemmer i forening eller af den administrerende direktør.
Company purpose
Selskabets formål er at drive virksomhed inden for industri og handel samt hermed beslægtet virksomhed, herunder helt eller delvist at eje andre selskaber.
Address
Arne Jacobsens Allé 13, 2.
Phone
+4597422299
Email
kundeservice.dk@abbott.com
Website
www.alere.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 31.967 | 19.448 | 19.999 | 23.434 | 18.702 | 18.159 | 14.949 | 15.279 | 9.984 | 9.955 | 10.273 | 6.159 | 2.231 |
| Staff expenses | -5.090 | -14.680 | -16.613 | -11.228 | -11.935 | -12.525 | -11.014 | -9.875 | -8.107 | -8.453 | -9.275 | -4.993 | -1.658 |
| EBITDA | 2.556 | 4.768 | 3.386 | 12.206 | 6.767 | 5.634 | 3.935 | 5.404 | 1.877 | 1.502 | 998 | 1.167 | 573 |
| Depreciation & amort. | -0 | -4.629 | -5.122 | -5.553 | -6.065 | -4.869 | -2.532 | -1.666 | -786 | -249 | -156 | -163 | -185 |
| EBIT | 2.556 | 139 | -1.736 | 6.653 | 703 | 765 | 1.403 | 3.738 | 1.090 | 1.254 | 842 | 1.003 | 388 |
| Net financials | -716 | -1.492 | -765 | -223 | -120 | -31 | -82 | -94 | -260 | -126 | -45 | 559 | 705 |
| Profit before tax | 1.840 | -1.353 | -2.501 | 6.431 | 583 | 734 | 1.321 | 3.644 | 831 | 2.256 | 797 | 1.562 | 1.093 |
| Tax | -0 | 455 | 335 | 2.351 | 912 | 634 | 337 | 805 | 184 | 1.446 | 100 | 342 | 239 |
| Net profit | 1.840 | -1.809 | -2.836 | 4.079 | -330 | 99 | 983 | 2.840 | 647 | 810 | 697 | 1.221 | 854 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 40.765 | 38.791 | 38.681 | 39.610 | 39.720 | 38.144 | 39.456 | 33.488 | 36.058 | 32.987 | 34.252 | 34.482 | 34.823 |
| Equity | -1.379 | -3.625 | 19.759 | 23.838 | 23.509 | 23.608 | 24.592 | 27.431 | 28.079 | 28.888 | 29.585 | 30.806 | 31.661 |
| Long-term debt | 28.945 | 29.017 | 5.017 | 5.017 | 0 | 0 | 2.199 | 0 | 3.957 | 0 | 0 | 0 | 0 |
| Short-term debt | 13.199 | 13.398 | 13.716 | 10.654 | 16.212 | 14.536 | 12.665 | 6.056 | 4.023 | 4.099 | 4.667 | 3.676 | 3.162 |
| Total debt | 42.144 | 42.416 | 18.733 | 15.672 | 16.212 | 14.536 | 14.864 | 6.056 | 7.980 | 4.099 | 4.667 | 3.676 | 3.162 |
EBITDA margin
25.7%
This company
15.8%
Market median
+63% vs market
20122024
Equity ratio
90.9%
This company
38.2%
Market median
+138% vs market
20122024
Return on equity
2.7%
This company
18.4%
Market median
-85% vs market
20122024
Net profit margin
38.3%
This company
8.1%
Market median
+373% vs market
20122024
Asset turnover
0.06×
This company
1.12×
Market median
-95% vs market
20122024
Debt / equity
0.10×
This company
0.62×
Market median
+84% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AS Management | Management | 2003 | — | — |
HK Chief Executive Officer | Chief Executive Officer | 2018 | — | — |
BL Chief Executive Officer | Chief Executive Officer | 2023 | — | — |
NB Management | Management | 2000 | — | — |
PA Management | Management | 2000 | — | — |
Lv Management | Management | 2013 | — | — |
CG Chief Executive Officer | Chief Executive Officer | 2017 | — | — |
AL Management | Management | 2014 | — | — |
JB Management | Management | 1999 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2008 | — | — | |
| Board of Directors | 2012 | — | — | |
| Board of Directors | 1999 | — | — | |
| Chairman | 2014 | — | — | |
| Board of Directors | 1999 | — | — | |
| Board of Directors | 2012 | — | — | |
| Chairman | 2023 | — | — | |
| Board of Directors | 2019 | — | — | |
| Board of Directors | 2013 | — | — | |
| Board of Directors | 2000 | — | — | |
| Chairman | 2000 | — | — | |
| Board of Directors | 2000 | — | — | |
| Board of Directors | 1999 | — | — | |
| Board of Directors | 2013 | — | — | |
| Board of Directors | 1999 | — | — | |
| Board of Directors | 2017 | — | — | |
| Board of Directors | 2012 | — | — | |
| Chairman | 2019 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2021 | |
| Individual | 100.0% | 100.0% | 2014 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Abbott Rapid Diagnostics A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Atle Schjøtt | Management | 0 companies |
| Henrik Kjeldsmark Jensen | Chief Executive Officer | 0 companies |
| Berit Landsend-Holo | Chief Executive Officer | 0 companies |
| Njaal Baardson | Management | 0 companies |
| Peter Albeck | Management | 0 companies |
| Lise von Seelen | Management | 0 companies |
| Christopher Gustaf Aulin | Chief Executive Officer | 0 companies |
| Andreas Lennart Gottlieb Juhlin | Management | 0 companies |
| Jørgen Byriel | Management | 0 companies |
| Kari Stenersen | Chairman | 0 companies |
| Hilde Eylenbosch | Board of Directors | 0 companies |
| Henrik Møgelmose | Board of Directors | 0 companies |
| Tomas Dan-Ola Blomqvist | Chairman | 0 companies |
| Vagn Thorup | Board of Directors | 0 companies |
| Véronique Yvonne Ameye | Board of Directors | 0 companies |
| Fredrik Björn Anders Björnulfson | Chairman | 0 companies |
| Thor Harald Kløver | Board of Directors | 0 companies |
| David Andrew Bond | Board of Directors | 0 companies |
| Oddvar Arne Vanberg | Board of Directors | 0 companies |
| Jane Catherine Karwoski | Chairman | 0 companies |
| Olav Steinnes | Board of Directors | 0 companies |
| Niels Henrik Balslev | Board of Directors | 0 companies |
| Kjersti Grimsrud | Board of Directors | 0 companies |
| Kurt Skovlund | Board of Directors | 0 companies |
| Brian B. Yoor | Board of Directors | 0 companies |
| Martyn Robert Pither | Board of Directors | 0 companies |
| Petter Aspaas | Chairman | 0 companies |